- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
健脾清肠汤治疗疡性结肠炎的临床研究
The clinical study of Spleen Qingchang soup On Ulcerative Coliticis
Speciality:Surgery of T.C.M
Author :Tian Junhong
Tutor:Professor Mei Xiaoling
Abstract
Objective: Ulcerative Coliticis is an inflammatory bowel disease of unknow etiology.
The disease course of a long, and often repeated attack, and the incdence of colon cancer
and to certain extent ,and thus difficult to cure by the world health organization as one.
Western medicine treatment of this disease are easy to relapse after treatment,long-term
medication reaction,intractable cases of shortcomings such as poor. So to find effective,less
side effects of drugs has become the focus of its research. Treatment of ulcerative colitis
with significant advantages in the development of outstanding value and broad
prospects.This paper summarized in the medical awareness of the disease, and evaluation
of clinical research soup jianpi qingchang the efficacy and mechanism for the treatment of
the disease to provide new and effective drugs. Methord: the subjects to Jianpi Qingchang
soup for the treatment of drug. Subject to the observation of patients with ycerative colitis
object. Topics observed clinical symptoms, signs, as the intestinal muosa colonoscopy,
IgG,IgA, IgA,IgM, ESR, CRP and C3. Choice of topics selected with the standard 60 cases
of patients.. A randomized, controlled clinical trial of parallel methods. Issue will be in
accordance with the principle of the patients were randomly divided into Jianpi Qingchang
group (experimental group) and sulfasalazine (control group), each of the 30cases.
Spleen test group taking the pral enema Qingchang soup control group given oral
sulfasalazine, and 1 g each, three times a day. One month for the two groups
文档评论(0)